Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Turkish Neurosurgery|May 5, 2023
Diabetes Mellitus-Mediated MALAT1 Expression Induces Glioblastoma AggressivenessAysen Akkurt Kocaeli, Secil Ak Aksoy, Melis Ercelik, et al.
Neurological Research|September 17, 2021
Long non-coding RNAs as a predictive markers of group 3 medulloblastomasMelis Mutlu, Cagla Tekin, Secil Ak Aksoy, et al.
Neurological Research|July 2, 2021
Coexistence of TERT C228T mutation and MALAT1 dysregulation in primary glioblastoma: new prognostic and therapeutic targetsSecil Ak Aksoy, Melis Mutlu, Berrin Tunca, et al.
Bosnian Journal of Basic Medical Sciences|September 4, 2019
Long noncoding RNA MALAT1 may be a prognostic biomarker in IDH1/2 wild-type primary glioblastomasOmer Gokay Argadal, Melis Mutlu, Secil Ak Aksoy, et al.
International Journal of Biological Macromolecules|September 6, 2023
Co-loading of Temozolomide with Oleuropein or rutin into polylactic acid core-shell nanofiber webs inhibit glioblastoma cell by controlled releaseMelis Ercelik, Cagla Tekin, Fatma Nur Parin, et al.
Pediatric Neurosurgery|March 21, 2021
NEAT1 Is a Novel Oncogenic LncRNA and Correlated with miR-143 in Pediatric OligodendrogliomasSecil Ak Aksoy, Melis Mutlu, Rabia Nur Balcin, et al.
Seminars in Cancer Biology|January 25, 2025
Leveraging epigenetic alterations in pancreatic ductal adenocarcinoma for clinical applicationsJorg Tost, Secil Ak-Aksoy, Daniele Campa, et al.
Asian Journal of Pharmaceutical Sciences|December 6, 2024
A new nano approach to prevent tumor growth in the local treatment of glioblastoma: Temozolomide and rutin-loaded hybrid layered composite nanofiberMelis Ercelik, Cagla Tekin, Melisa Gurbuz, et al.
Pageof 2